Search results
Pivotal advancement in the treatment of small cell lung cancer
KHGI Nebraska TV· 2 days ago1 in 16 Americans will face a lung cancer diagnosis in their lifetime.Lung cancer is a complex and...
Lisata Therapeutics (NASDAQ:LSTA) Stock Price Up 6.4%
ETF DAILY NEWS· 4 days agoLisata Therapeutics, Inc. (NASDAQ:LSTA – Get Free Report) shares traded up 6.4% on Tuesday . The stock traded as high as $3.70 and last traded at $3.67.
Cara Therapeutics (NASDAQ:CARA) Downgraded by HC Wainwright to Neutral
ETF DAILY NEWS· 1 day agoHC Wainwright downgraded shares of Cara Therapeutics (NASDAQ:CARA – Free Report) from a buy rating to a neutral rating in a report issued on Thursday, MarketBeat.com reports. CARA has been the ...
3 PEG-Based Value Picks to Boost Your Portfolio Returns
Zacks· 2 days agoIn a market dealing with external shocks, value investing, or the strategy of putting money in...
ProKidney (NASDAQ:PROK) Given New $6.00 Price Target at Jefferies Financial Group
ETF DAILY NEWS· 5 days agoProKidney (NASDAQ:PROK – Free Report) had its target price reduced by Jefferies Financial Group from $15.00 to $6.00 in a research note released on Monday, Benzinga reports. Jefferies Financial ...
The Secret to Living Past 120 Years Old? Nanobots
Wired News· 2 days agoIn the 2020s we are starting the second phase of life extension, which is the merger of biotechnology with AI. The 2030s will usher in the third phase of...
First Generation to Have More Cancer Than Their Parents
Medscape· 4 days agoBut how worried should we be? Dr F Perry Wilson breaks it all down.
Fresenius Medical Care (ETR:FME) Shares Cross Above Two Hundred Day Moving Average of $37.31
ETF DAILY NEWS· 3 days agoFresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €37.31 ($40.12) and traded ...
Iomab-B shows promise in high-risk leukemia treatment By Investing.com
Investing.com· 5 days agoThe Phase 3 SIERRA trial data indicated that Iomab-B, a targeted radiotherapy, met its primary...
Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure,...
Digital Journal· 3 days agoRenova is exploring new therapeutic opportunities that have the potential to expand the use of Renova's gene therapy platform to include several pathologies associated with diabetes and heart ...